Purchase this article with an account.
K. G. Tokuhara, M. Rauser, J. Narvaez; Short Term Visual Outcomes of the Alcon Toric Intraocular Lens. Invest. Ophthalmol. Vis. Sci. 2008;49(13):404.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
The Alcon Toric Intraocular lens (IOL), which has recently become available over the past year, offers the promise of achieving better postoperative uncorrected visual acuity compared to standard intraocular lenses for patients with astigmatism. The purpose of this study is to evaluate the short term postoperative uncorrected visual acuity of astigmatic patients undergoing cataract surgery with the Alcon Toric IOL at their one week and one month postoperative clinic visits.
A retrospective review of the medical records of all patients at the Loma Linda University Department of Ophthalmology who underwent implantation of the Alcon Toric Intraocular Lens (IOL) from March 12, 2007 through September 12, 2007 by Dr. Michael Rauser and Dr. Julio Narvaez.
A total of 49 surgical eyes were reviewed. Of the type of lens implanted, 22 (44.9%) were T3, 15 (30.6%) were T4, and 12 (24.5%) were T5. One month post-operative uncorrected visual acuity was better or equal to 20/40 in 46 eyes (93.9%), better than or equal to 20/30 in 41 eyes (83.7%), and better than or equal to 20/25 in 30 eyes (61.2%). Post-operative visual outcomes were limited in cases of dry eyes (4 eyes), nonexudative macular degeneration (2 eyes), epiretinal membrane (1 eye), and posterior subcapsular opacity (1 eye).
The majority of astigmatic patients receiving the Alcon Toric IOL have good post-operative uncorrected visual acuity.
This PDF is available to Subscribers Only